NAD finds support for Kinoko AHCC claims
This article was originally published in The Tan Sheet
Executive SummaryThe mushroom-derived ingredient active hexose correlated compound shows immune-support benefits, though Quality of Life Labs should tweak its advertising language for Kinoko AHCC and Kinoko AHCC Gold, the National Advertising Division finds. The Purchase, N.Y.-based firm should clarify that data showing improved immune response and enhanced macrophage and T-cell activity are associated with the ingredient and not its products, the Council of Better Business Bureaus unit said May 28. Additionally, Quality of Life should revise its claim that the supplement is supported by "over 80 research studies," since NAD found the actual number was much lower, and should disclose that the immune benefits studied occurred in individuals with compromised immune systems. The company praised NAD's conclusions as "accurate and insightful" and said it will comply
You may also be interested in...
Last week, the Commission revealed that three more notified bodies had been designated; but their listings had not been made official. Now we learn that one of the three is in the Netherlands as the first listing takes place.